Endometrial Carcinomas With a Somatically Derived Yolk Sac Tumor Component Share Molecular Similarities to p53–abnormal Endometrial Carcinomas and Germ Cell Tumors
Modern Pathology · 2026
DOI: 10.1016/j.modpat.2026.100976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Joshua J X Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pok Fu Lam Road, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Endodermal Sinus Tumor, Endometrial Neoplasms, Tumor Suppressor Protein p53, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese University of Hong Kong.
Abstract (Originalsprache)
Primary endometrial carcinomas with somatically derived yolk sac tumor (YST) components are rare. We analyzed 23 such cases using detailed clinicopathologic, immunohistochemical, and molecular methods. The median patient age was 68 years. Elevated serum alpha-fetoprotein (AFP) was detected in 76.9% (10/13) of tested cases. International Federation of Gynecology and Obstetrics (FIGO) 2009 stages were I (n = 12, 55%), II (n = 1, 5%), III (n = 5, 23%), IV (n = 4, 18%), and unknown in one. Histologic YST patterns included glandular (87%), papillary (52%), solid (48%), endodermal sinus (17%), hepatoid (17%), and reticular (13%) architectures. The associated Müllerian-type neoplasms were endometrioid carcinoma (n = 17), carcinosarcoma (n = 3), serous carcinoma (n = 2), and clear cell carcinoma (n = 1). Immunohistochemically, 17 cases (74%) exhibited mutation-type p53 staining, and 2 (9%) were mismatch repair-deficient (MMRd). YST components uniformly expressed glypican-3 and spalt-like transcription factor 4 (SALL4), whereas 17 (74%) also expressed AFP. HER2 positivity was seen in 13 of 21 tested (62%; four 3+, three 2+, and six 1+). Molecular analysis revealed TP53 variants in 16 of 22 cases (73%) without POLE hotspot mutations. According to The Cancer Genome Atlas molecular classification, 17 tumors were p53-abnormal (74%), 2 (9%) MMRd, 4 (17%) were no specific molecular profile, and none was POLE-ultramutated. Recurrent copy number gains involved CCNE1 (9/22, 41%), 1q44 (12/14, 86%), and 3q26.32 (8/14, 57%). Features reminiscent of germ cell tumors included amplifications at 7p21.2 (8/14, 57%) and 9p21.3 (11/14, 79%), polysomy or amplification of chromosome 12p (6/22, 27%), deletion at 11q24.3 (8/14, 57%), and a high frequency of T>C nucleotide substitutions. Follow-up showed 15 patients (75%) had died of disease or were alive with disease; 12 of these 15 cases were p53-abnormal. Overall survival was significantly poorer than in other molecular subtypes of endometrial carcinoma. These tumors should therefore be regarded as high grade (grade 3) by definition. In summary, endometrial carcinomas with a somatically derived YST component are highly aggressive, predominantly p53-abnormal, with smaller subsets classified as MMRd or no specific molecular profile. Recognition of the YST component is crucial, and biomarker profiling may reveal therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pok Fu Lam Road, Hong Kong SAR, China.
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Pathology, Belfast Health and Social Care Trust, Belfast, United Kingdom.
- Department of Pathology, University of California San Diego, San Diego, California, USA.
- Department of Pathology, College of Medicine, University of The Philippines, Manila, Philippines.
- Department of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
Förderung
- Chinese University of Hong Kong
Zitieren
APA
Li, J. J. X., Chui, M. H., McCluggage, W. G., Fadare, O., Cheng, G. H. W., Ko, J. M. K., Dungog, C. C., Lee, J. H. S., Ma, E. S. K., Tse, K. Y., & Ip, P. P. C. (2026). Endometrial Carcinomas With a Somatically Derived Yolk Sac Tumor Component Share Molecular Similarities to p53–abnormal Endometrial Carcinomas and Germ Cell Tumors. Modern Pathology. https://doi.org/10.1016/j.modpat.2026.100976
Vancouver
Li JJX, Chui MH, McCluggage WG, Fadare O, Cheng GHW, Ko JMK, et al. Endometrial Carcinomas With a Somatically Derived Yolk Sac Tumor Component Share Molecular Similarities to p53–abnormal Endometrial Carcinomas and Germ Cell Tumors. Modern Pathology. 2026. doi:10.1016/j.modpat.2026.100976
BibTeX
@article{Li2026,
author = {Li, Joshua J X and Chui, M Herman and McCluggage, W Glenn and Fadare, Oluwole and Cheng, Grace H W and Ko, Jasmine M K and Dungog, Cecile C and Lee, Jacqueline H S and Ma, Edmond S K and Tse, Ka Yu and Ip, Philip P C},
title = {Endometrial Carcinomas With a Somatically Derived Yolk Sac Tumor Component Share Molecular Similarities to p53–abnormal Endometrial Carcinomas and Germ Cell Tumors},
journal = {Modern Pathology},
year = {2026},
doi = {10.1016/j.modpat.2026.100976}
}
EUVIMED